All Posts Tagged With: "GlaxoSmithKline"
Glaxo Dismisses Avandia Liver Failure Risk
Following a petition filed last week by the consumer advocacy group Public Citizen, which called for an Avandia recall due to a risk of liver failure and other life-threatening injuries, GlaxoSmithKline has issued a statement dismissing the claim that there are liver safety issue caused by side effects of Avandia. Continued
Avandia Recall Urged by Consumer Group
The consumer advocacy group Public Citizen has filed a petition with the FDA calling for an Avandia recall as a result of a number of serious and potentially life threatening side effects associated with the diabetes drug. Continued
Avandia Lawsuits
Users of the diabetes drug Avandia face a potential increased risk of serious and potentially fatal injuries. Lawsuits are being investigated throughout the United States for users who suffered a heart attack, stroke, congestive heart failure, bone fractures or death. Continued
Avandia Wrongful Death Lawsuit Filed in California
A California wrongful death lawsuit has been filed against the makers of Avandia, alleging that the Type 2 diabetes drug caused heart attacks, congestive heart failure, and other cardiovascular injuries which killed seven people. Continued
Avandia Warning Label Updated To Indicate Blood Sugar Control Benefits
GlaxoSmithKline is updating the prescribing information for Avandia to include clinical findings that users have better glycemic control with the drug than with two other diabetes treatments. However, critics who have voiced safety concerns about Avandia, point out that the better control of blood sugar is not particularly useful, since side effects of the drug could increase the risk of a potentially fatal heart attack. Continued
